Mulmit

SELLAS Life Sciences Group, Inc.SELLAS Life Sciences Group, Inc.

SLS Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2023-12-310-37,869,000-37,340,000-1.34
2022-12-311,000,000-41,950,000-41,301,000-2.13
2021-12-317,600,000-25,294,000-20,699,000-1.34
2020-12-311,900,000-16,982,000-16,757,000-2.11
2019-12-310-20,041,000-19,292,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-16Stergiou Angelos M.President and CEO1,065,000
2026-01-07Varian John50,000
2026-01-07VAN NOSTRAND ROBERT L50,000
2026-01-07SCHEINBERG DAVID A50,000
2026-01-07CICIC DRAGANSVP, Chief Development Officer300,000
2026-01-07Burns John ThomasCFO300,000
2026-01-07Kalin Katherine Bach50,000
2026-01-07Wasman Jane50,000
2025-12-03CICIC DRAGANSVP, Chief Development Officer63,800
2025-12-03Burns John ThomasCFO58,592
2025-12-03Stergiou Angelos M.President and CEO187,066
2025-11-19Kalin Katherine Bach63,400

8-K events

FiledItems
2026-08-11Results of operations · Financial statements and exhibits
2026-07-27Results of operations · Other events · Financial statements and exhibits
2026-06-25Officer or director change · Financial statements and exhibits
2026-06-18Submission of matters to a vote
2026-06-02Other events · Financial statements and exhibits
2026-05-12Results of operations · Financial statements and exhibits
2026-03-19Results of operations · Financial statements and exhibits
2026-03-11Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…